News Previous Next
‘Game-changer’ drug will not be available on NHS
The Institute of Cancer Research (ICR) has expressed disappointment that the prostate cancer drug abiraterone will not be made available to men with advanced prostate cancer as a first-line treatment on the NHS.
Cancer Nursing Practice. 17, 4, 7-7. doi: 10.7748/cnp.17.4.7.s4